The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 1,200
- Locations
- 1
- Primary Endpoint
- Overall survival
Study Overview
Brief Summary
The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is:
- The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.
Researchers will investigate the features, survival associated factors and other relevant factors of this population.
Detailed Description
The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is:
- The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers.
Researchers will investigate the features, survival associated factors and other relevant factors of this population.
The collected variables included: survival time, survival status, year of diagnosis, age, stage, molecular subtype statuses, histology, grade, and surgery, radiotherapy and systemic therapies utilization.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Male
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Biological sex is male;
- •Microscopically diagnosed as primary breast cancer.
Exclusion Criteria
- •Presence of skin-origin malignancy on the breast.
Outcomes
Primary Outcomes
Overall survival
Time Frame: From the time of diagnosis to August 1, 2024 (anticipated).
The duration between the date of the first pathologic diagnosis and death from any cause or last follow-up.
Secondary Outcomes
No secondary outcomes reported
Investigators
Ying Lin
MD, PhD
First Affiliated Hospital, Sun Yat-Sen University